https://pharmaphorum.com/ en Sat, 14 Sep 2024 19:40:05 +0000 Fri, 13 Sep 2024 11:04:52 +0000 https://pharmaphorum.com/news/lilly-ramps-irish-manufacturing-investment-1bn Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has opted to double its investment in the site, taking the total above $2 billion and reinforcing the company's close ties to Ireland's pharma manufacturing sector. Phil.Taylor https://pharmaphorum.com/news/lilly-ramps-irish-manufacturing-investment-1bn 2024-09-13T10:37:27+0000 Feed - News and features https://pharmaphorum.com/news/syneos-health-communications-takes-crown-pm-society-digital-awards The PM Society Digital Awards 2024 held its 15th ceremony at The Brewery in London on 12th September Eloise.McLennan https://pharmaphorum.com/news/syneos-health-communications-takes-crown-pm-society-digital-awards 2024-09-13T11:04:52+0000 Feed - News and features https://pharmaphorum.com/news/apple-airpods-get-fda-okay-use-otc-hearing-aids It's known that excessive use of earbuds at high volumes can cause hearing loss, so somewhat ironic that the FDA has just authorised software that can turn Apple AirPods into hearing aids.The green light is for Hearing Aid Feature (HAF), an app compatible with Apple's AirPods Pro earbuds that amplifies sounds and can be used for people aged 18 and over with perceived mild to moderate hearing impairment. Phil.Taylor https://pharmaphorum.com/news/apple-airpods-get-fda-okay-use-otc-hearing-aids 2024-09-13T10:07:34+0000 Feed - News and features https://pharmaphorum.com/news/us-puts-25m-behind-cellinos-cell-and-tissue-printing-tech Cellino Biotech has received funding from the US government to develop a scalable biomanufacturing platform for personalised regenerative medicines derived from patients' own stem cells.The $25 million award from the Advanced Research Projects Agency for Health (ARPA-H) will be used to develop Cellino's NEBULA system, which, according to the firm's chief technology officer, Matthias Wagner, can "effectively print new cells and new tissues for patients using their own DNA." Phil.Taylor https://pharmaphorum.com/news/us-puts-25m-behind-cellinos-cell-and-tissue-printing-tech 2024-09-13T08:31:28+0000 Feed - News and features https://pharmaphorum.com/news/armed-100m-funding-f2g-prepares-refile-antifungal UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA.The Manchester-based company said the new cash will help it to complete the late-stage development of olorofim, a novel oral antifungal for invasive aspergillosis and other serious fungal infections, to support the company during the regulatory review process, and prepare for a commercial launch in the US. Phil.Taylor https://pharmaphorum.com/news/armed-100m-funding-f2g-prepares-refile-antifungal 2024-09-13T07:31:33+0000 Feed - News and features